Noswab saliva test for coronavirus piloted in Britain Reuters Discover Thomson ReutersFinancialGovernment SolutionsLegalReuters News AgencyRisk Management SolutionsTax AccountingBlog Answers OnInnovation Thomson ReutersDirectory of sitesLoginContactSupportBusinessMarketsWorldPoliticsTVMoreUnited States World NewsJune 22 2020 301 PM Updated an hour agoNoswab saliva test for coronavirus piloted in Britain2 Min ReadFILE PHOTO Military personnel are seen at a drivethrough coronavirus disease COVID19 testing facility in Hyde Park following the outbreak of the coronavirus disease London Britain June 11 2020REUTERSToby MelvilleLONDON Reuters A weekly coronavirus testing regime using a noswab saliva test is being trialled in Southampton southern England and could result in a simpler and quicker way to detect outbreaks of the virus the British government said on MondaySaliva testing could potentially make it even easier for people to take coronavirus tests at home without having to use swabs said Health Secretary Matt HancockThis trial will also help us learn if routine athome testing could pick up cases of the virus earlier More than 14000 doctors and health workers other essential workers and university staff and their households will participate in the trial which uses an Optigene test the government saidRather than taking a swab which some people find uncomfortable participants will spit into a potTest results will be received within 48 hours the government saidThe pilot will be jointly led by Southampton City Council the University of Southampton and the staterun health service alongside a wider network of public services in HampshireThe government said it was also exploring the potential of other noswab saliva based coronavirus tests with companies including Chronomics Avacta AVTGL MAP Science and Oxford Nanoimaging ONIIt said it was also working with suppliers including DNA Genotek International Scientific Supplies Ltd Isohelix and other leading manufacturers to develop bespoke saliva collection kits and scale up manufacturing for products that can be used with existing PCR testsReporting by Paul Sandle editing by Estelle ShirbonOur StandardsThe Thomson Reuters Trust PrinciplesSponsored Video by Getting the most from your investment portfolioLearn MoreVideo Player is loadingUnmuteLoaded 0Current Time 0001xPlayback Rate2x175x15x125x1x selected075x05xSubtitlessubtitles off selectedOpen quality selector menuStart AirPlayFullscreenThis is a modal windowBeginning of dialog windowEscape will cancel and close the windowTextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemiTransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemiTransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemiTransparentOpaqueFont Size5075100125150175200300400Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional SansSerifMonospace SansSerifProportional SerifMonospace SerifCasualScriptSmall CapsReset restore all settings to the default valuesDoneClose Modal DialogEnd of dialog windowVideo Ad by TrendingReuters News NowSubscribe to our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inboxSubmit1366 576narrowbrowserandphonemediumbrowserandportraittabletlandscapetabletmediumwidebrowserwidebrowserandlargermediumbrowserandlandscapetabletmediumwidebrowserandlargerabovephoneportraittabletandaboveaboveportraittabletlandscapetabletandabovelandscapetabletandmediumwidebrowserportraittabletandbelowlandscapetabletandbelowAppsNewslettersAdvertise with UsAdvertising GuidelinesCookiesTerms of UsePrivacyAll quotes delayed a minimum of 15 minutesSee here for a complete list of exchanges and delays 2020 ReutersAll Rights ReservedX We value your feedbackPlease answer this short 2 question survey to help Reuters improve our experienceTAKE THE SURVEY